Wedge Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,159
| Closed | -$283K | – | 588 |
|
|
2020
Q1 | $283K | Buy |
6,159
+751
| +14% | +$34.5K | ﹤0.01% | 409 |
|
|
2019
Q4 | $325K | Buy |
5,408
+675
| +14% | +$40.6K | ﹤0.01% | 465 |
|
|
2019
Q3 | $268K | Buy |
+4,733
| New | +$268K | ﹤0.01% | 498 |
|
|
2018
Q3 | – | Sell |
-6,732
| Closed | -$509K | – | 600 |
|
|
2018
Q2 | $509K | Buy |
+6,732
| New | +$509K | 0.01% | 459 |
|